Podcast Episodes
Back to SearchGene Therapy Manufacturing At-Scale With Geoff MacKay
We love to hear from our listeners. Send us a message.
Listen in as AVROBIO President & CEO Geoff MacKay tells the Business Of Biotech about the tech…
5 years, 4 months ago
Bacterial Therapy: Modulation of the Microbiome With Dr. Bernat Olle
We love to hear from our listeners. Send us a message.
Dr. Bernat Olle discusses the pioneering work his company, Vedanta Biosciences, is doing to mo…
5 years, 4 months ago
Foundations Of Biopharma Finance With Smital Shah
We love to hear from our listeners. Send us a message.
Smital Shah brings a trifecta of chemical engineering, consulting, and finance experience earn…
5 years, 5 months ago
Off-The-Shelf CAR T-Cell Therapy with John McKearn, Ph.D.
We love to hear from our listeners. Send us a message.
Find out what drove John McKearn, Ph.D. & CEO at Wugen, out of the lab at Pfizer and on to his…
5 years, 5 months ago
CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.
We love to hear from our listeners. Send us a message.
Controlling the cost of personalized medicine: We go behind the scenes of the effort to build …
5 years, 6 months ago
010: Gap Analysis With Dr. Pablo Valenzuela & Cristián Hernández-Cuevas
We love to hear from our listeners. Send us a message.
We're joined by biopharma pioneer Dr. Pablo Valenzuela and rising star Cristián Hernández-Cuev…
5 years, 6 months ago
009: CMC Considerations For In-Human Studies with Drs. Edith Perez & Nathan Ihle
We love to hear from our listeners. Send us a message.
Bolt Biotherapeutics CMO Dr. Edith Perez and VP of CMC & Quality Dr. Nathan Ihle bring a uniqu…
5 years, 6 months ago
008: Commitment To GMP With Dr. Shabbir Anik
We love to hear from our listeners. Send us a message.
Sutro Biopharma Chief Technical Operations Officer Shabbir Anik has contributed to 15 INDs and…
5 years, 7 months ago
007: Quality Data For FDA Submissions With Dr. Robert Hariri
We love to hear from our listeners. Send us a message.
If ever a biotech unwittingly begged for FDA scrutiny by virtue of its business model, it was …
5 years, 7 months ago
Summer Sessions 8: Dr. Gaurav Shah, Rocket's Chief Gene Therapist & Virtuoso
We love to hear from our listeners. Send us a message.
Rocket Pharmaceuticals CEO Dr. Gaurav Shah shares the parallels between his leadership in the …
5 years, 7 months ago